21 results
8-K
ohxwrnrz
16 Jun 21
Satsuma Pharmaceuticals Announces Positive Pharmacokinetic, Tolerability and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
4:29pm
8-K
EX-99.2
05teq
1 Mar 21
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
12:00am
10-K
inmbhcy
10 Mar 20
Annual report
4:20pm
10-Q
88rc a4pagahi
12 Nov 19
Quarterly report
4:31pm
424B4
zz7re hq00cuors
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
jon2g7 c9u3xqs
3 Sep 19
IPO registration (amended)
6:12am
S-1
dog267w
16 Aug 19
IPO registration
5:15pm
DRS/A
h5j8o8m9k
2 Aug 19
Draft registration statement (amended)
12:00am